A life settlement is the sale of an existing life insurance policy to a third party for more than its cash surrender value but less than its death benefit. The original policyholder — typically an elderly or terminally ill person who no longer needs the coverage, or can no longer afford the premiums — receives an immediate lump sum. The buyer takes over premium payments and receives the death benefit when the insured dies. The life settlement market processes approximately $4 billion in face value annually in the United States, growing steadily as the population ages and awareness of the option increases.
It is also one of the most structurally complex, illiquid, and opaque asset classes in institutional alternative finance — and an almost perfect candidate for tokenization.
Why Life Settlements Are Attractive as an Investment
Life settlements have three characteristics that make them attractive to institutional investors seeking uncorrelated returns. First, their return profile is determined by actuarial mortality data, not by financial market movements. A portfolio of life settlements performs based on when the insureds die — which has essentially zero correlation with whether the S&P 500 goes up or down. During the 2008 financial crisis, life settlement returns were positive. During COVID-19 market volatility, they were largely unaffected by equity market movements (though they were affected by excess mortality from COVID itself).
Second, they are backed by one of the most credit-worthy instruments in finance: an insurance company's contractual obligation to pay the death benefit. The credit risk is the insurance company, not the policyholder. Major US life insurers carry AA and AAA credit ratings.
Third, yields are substantial — typically 8–14% net of premium costs — reflecting the illiquidity premium and the complexity of underwriting mortality risk. The Chartered Alternative Investment Analyst (CAIA) curriculum includes life settlements as a standard institutional alternative asset class.
The Problems Tokenization Solves
The life settlement market's chronic inefficiencies are exactly the problems blockchain is built to address.
Illiquidity. Once an investor buys a life settlement policy, exiting is difficult. There is no organized secondary market. Finding a buyer requires engaging specialist brokers, sharing confidential medical information about the insured (with consent), and waiting weeks or months for due diligence. Tokenized interests in a life settlement portfolio could trade on a secondary market with standardized documentation and blockchain-recorded ownership transfers — dramatically reducing the exit friction that makes life settlements prohibitive for all but the largest institutional investors.
Opacity. The life settlement market is characterized by information asymmetry. Providers who originate policies have access to actuarial data, medical underwriting, and policy terms that secondary buyers cannot easily verify. Blockchain recording of policy status, premium payment history, and medical underwriting data (with appropriate privacy protections) creates an auditable record that reduces information asymmetry between originators and investors.
Minimum investment size. A single life insurance policy might have a face value of $500,000 to $5 million. Institutional funds that invest in life settlement portfolios typically require $5 million minimums. Tokenizing a pool of policies as fractional interests — in the same way mortgage-backed securities fractionate individual mortgages — could make the asset class accessible at $10,000 or $50,000 minimums, dramatically expanding the potential investor base.
The Legal and Regulatory Landscape
Life settlements are regulated at the state level in the United States — 43 states have enacted life settlement laws, covering the disclosure requirements, waiting periods, and broker licensing standards for policy sales. Tokenizing life settlement interests would layer federal securities law on top of existing state regulation: a tokenized life settlement fund would likely be structured as a registered investment company or offered under Regulation D to accredited investors.
The privacy dimension is the most complex regulatory challenge. Life settlement valuation depends on the insured's medical history and life expectancy — sensitive health information protected under the Health Insurance Portability and Accountability Act (HIPAA). Blockchain's transparency creates tension with HIPAA's confidentiality requirements. The most credible tokenization structures address this by keeping medical information off-chain in encrypted form, with blockchain recording only the financial parameters (policy face value, premium schedule, ownership interests) rather than the underlying health data.
Who Is Building It
Several platforms are developing tokenized life settlement infrastructure. Abacus Life — a publicly traded life settlement company — has been exploring tokenized secondary market infrastructure. Beneficient, which provides liquidity solutions for alternative asset holders, has tokenized interests in alternative asset portfolios that include life settlements. The technical architecture is well-understood; the regulatory pathway for a fully tokenized, publicly tradeable life settlement product remains the primary constraint.
→ How to evaluate an RWA project — the due diligence framework
→ Private credit — the adjacent institutional alternative asset class
→ Mortgage-backed securities — the original securitization that tokenization extends